Connection

SHELDON KAPLAN to Streptococcus pneumoniae

This is a "connection" page, showing publications SHELDON KAPLAN has written about Streptococcus pneumoniae.
Connection Strength

5.799
  1. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
    View in: PubMed
    Score: 0.395
  2. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010 Mar; 125(3):429-36.
    View in: PubMed
    Score: 0.280
  3. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
    View in: PubMed
    Score: 0.271
  4. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008 Jul; 122(1):34-9.
    View in: PubMed
    Score: 0.250
  5. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
    View in: PubMed
    Score: 0.232
  6. Pneumococcal endocarditis in children. Clin Infect Dis. 2004 May 01; 38(9):1273-8.
    View in: PubMed
    Score: 0.187
  7. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 Mar; 113(3 Pt 1):443-9.
    View in: PubMed
    Score: 0.185
  8. Amoxicillin and penicillin G dosing in pediatric community-acquired pneumococcal pneumonia in the era of conjugate pneumococcal vaccines. Pharmacotherapy. 2024 Aug; 44(8):606-614.
    View in: PubMed
    Score: 0.171
  9. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother. 2003 Jan; 47(1):166-9.
    View in: PubMed
    Score: 0.171
  10. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002 Apr; 31(4):250-60.
    View in: PubMed
    Score: 0.162
  11. Pneumococcal research transformed. N Engl J Med. 2001 Oct 18; 345(16):1206-7.
    View in: PubMed
    Score: 0.157
  12. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
    View in: PubMed
    Score: 0.153
  13. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
    View in: PubMed
    Score: 0.151
  14. Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
    View in: PubMed
    Score: 0.146
  15. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 1998 Dec; 102(6):1369-75.
    View in: PubMed
    Score: 0.129
  16. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998 Oct; 11(4):628-44.
    View in: PubMed
    Score: 0.127
  17. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998 Sep; 102(3 Pt 1):538-45.
    View in: PubMed
    Score: 0.126
  18. Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
    View in: PubMed
    Score: 0.121
  19. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
    View in: PubMed
    Score: 0.120
  20. Streptococcus pneumoniae: impact of antibiotic resistance in pediatrics. Curr Probl Pediatr. 1997 May-Jun; 27(5):187-95.
    View in: PubMed
    Score: 0.115
  21. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.113
  22. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
    View in: PubMed
    Score: 0.112
  23. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996 Apr; 40(4):1039-40.
    View in: PubMed
    Score: 0.107
  24. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother. 1995 Dec; 36(6):1043-8.
    View in: PubMed
    Score: 0.104
  25. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin Infect Dis. 2015 Sep 01; 61(5):767-75.
    View in: PubMed
    Score: 0.101
  26. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections. Semin Respir Infect. 1995 Mar; 10(1):31-6.
    View in: PubMed
    Score: 0.099
  27. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
    View in: PubMed
    Score: 0.096
  28. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J. 1994 Jul; 13(7):585-9.
    View in: PubMed
    Score: 0.095
  29. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May; 38(5):918-23.
    View in: PubMed
    Score: 0.094
  30. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Mar; 32(3):203-7.
    View in: PubMed
    Score: 0.086
  31. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013 Apr; 51(4):1294-7.
    View in: PubMed
    Score: 0.086
  32. Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010. J Clin Microbiol. 2012 Apr; 50(4):1326-30.
    View in: PubMed
    Score: 0.080
  33. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
    View in: PubMed
    Score: 0.076
  34. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine. 2010 Jun 11; 28(26):4249-59.
    View in: PubMed
    Score: 0.071
  35. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J. 2006 Apr; 25(4):301-5.
    View in: PubMed
    Score: 0.053
  36. Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States. J Clin Microbiol. 2004 Jun; 42(6):2810-2.
    View in: PubMed
    Score: 0.047
  37. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
    View in: PubMed
    Score: 0.047
  38. Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003 Nov; 112(5):1095-102.
    View in: PubMed
    Score: 0.045
  39. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
    View in: PubMed
    Score: 0.044
  40. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002 Nov; 21(11):1008-16.
    View in: PubMed
    Score: 0.042
  41. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002 Jul; 110(1 Pt 1):1-6.
    View in: PubMed
    Score: 0.041
  42. Management of pneumococcal meningitis. Pediatr Infect Dis J. 2002 Jun; 21(6):589-91; discussion 613-4.
    View in: PubMed
    Score: 0.041
  43. The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children. Pediatr Infect Dis J. 2021 08 01; 40(8):e313-e316.
    View in: PubMed
    Score: 0.039
  44. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
    View in: PubMed
    Score: 0.037
  45. Pneumococcal facial cellulitis in children. Pediatrics. 2000 Nov; 106(5):E61.
    View in: PubMed
    Score: 0.037
  46. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998 Nov; 102(5):1087-97.
    View in: PubMed
    Score: 0.032
  47. Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):249-252.
    View in: PubMed
    Score: 0.032
  48. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2017 Jun 15; 64(12):1699-1704.
    View in: PubMed
    Score: 0.029
  49. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrob Agents Chemother. 1996 Apr; 40(4):895-8.
    View in: PubMed
    Score: 0.027
  50. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J. 1995 Dec; 14(12):1037-41.
    View in: PubMed
    Score: 0.026
  51. Hematogenous bacterial meningitis in an intercellular adhesion molecule-1-deficient infant mouse model. J Infect Dis. 1995 Feb; 171(2):342-9.
    View in: PubMed
    Score: 0.025
  52. Resistant Pneumococcus: a worldwide problem. Infection. 1994 Jul-Aug; 22(4):233-7.
    View in: PubMed
    Score: 0.024
  53. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec; 92(6):761-7.
    View in: PubMed
    Score: 0.023
  54. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992 Dec; 90(6):928-33.
    View in: PubMed
    Score: 0.021
  55. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug; 36(8):1703-7.
    View in: PubMed
    Score: 0.021
  56. New aspects of prevention and therapy of meningitis. Infect Dis Clin North Am. 1992 Mar; 6(1):197-214.
    View in: PubMed
    Score: 0.020
  57. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr. 1991 Dec; 119(6):941-4.
    View in: PubMed
    Score: 0.020
  58. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005 Jun 15; 40(12):1738-44.
    View in: PubMed
    Score: 0.013
  59. Ampicillin and penicillin concentration in serum and pleural fluid of hospitalized children with community-acquired pneumonia. Pediatr Infect Dis J. 2004 Jul; 23(7):625-9.
    View in: PubMed
    Score: 0.012
  60. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004 Jun; 113(6):1735-40.
    View in: PubMed
    Score: 0.012
  61. The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae. J Immunol. 2001 Jun 15; 166(12):7362-9.
    View in: PubMed
    Score: 0.010
  62. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998 Dec; 102(6):1376-82.
    View in: PubMed
    Score: 0.008
  63. Effects of causative organism and presence or absence of meningitis on white blood cell counts in children with bacteremia. J Emerg Med. 1988 Jan-Feb; 6(1):33-5.
    View in: PubMed
    Score: 0.004
  64. Association between persistence of pneumococcal meningitis and dexamethasone administration. J Pediatr. 1981 Dec; 99(6):924-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.